Published

Cost-Effectiveness of Psilocybin-Assisted Therapy (PAT) for Patients with Treatment-Resistant Depression

Conference poster presented at ISPOR 2026, Philadelphia, May 2026. Co-authors: Yosr Ziadi, Taehwan Park. St. John's University.

Open source BibTeX RIS

Bibliographic context

Journal: Open MIND
Date: 2025-12-31
Source: OpenAlex
DOI: 10.17605/osf.io/nrt59
PubMed: Unavailable

Authors

Yosr Ziadi Taehwan Park

Watch author

Topics and keywords

psilocybin Depression Chronic Pain Clinical Trial Treatment-Resistant Depression Clinical Trial Medicine Depression (economics)Internal medicine MEDLINE Clinical trial Intensive care medicine Disease Psychiatry Treatment-resistant depression Context (archaeology)Psychedelics and Drug Studies Cannabis and Cannabinoid Research Pain Management and Placebo Effect

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21 Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-24 THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERSInternational Journal of Innovative Technologies in Social Science · 2026-01-22 Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-11